Fatigue and Carnitine Levels over Eight Cycles of Chemotherapy in Children and Adolescents.
|
Baylor College of Medicine / Marilyn Hockenberry |
Nurse Researcher Grants |
2008 |
Texas |
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity |
University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD |
Innovation Grants |
2018 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Parallel sequencing to identify the causes of childhood cancer.
|
Baylor College of Medicine / Sharon Plon, MD, PhD |
Innovation Grants |
2006 |
Texas |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML |
Baylor College of Medicine / Michele Redell, M.D./Ph.D. |
Springboard Grants |
2014 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Center for Pediatric T Cell Therapy (CEPET) |
Baylor College of Medicine / Cliona Rooney |
Phase I/II Infrastructure Grants |
2010 |
Texas |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |